Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spleen tyrosine kinase (SYK) recruitment to the Fc epsilon RI (FcεRI) gamma subunit is a critical step in mast cell and basophil activation following allergen exposure. Allergen-induced crosslinking of IgE bound to FcεRI leads to LYN-mediated phosphorylation of ITAMs on the γ subunits. These phosphorylated ITAMs then serve as docking sites for SYK, initiating downstream signaling cascades that result in degranulation and cytokine release. This pathway is central to allergic reactions.
SYK inhibitors block SYK kinase activity, preventing downstream signaling cascades.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spleen Tyrosine Kinase Recruitment to Fc Epsilon RI Gamma Subunit.